Даваа–Баасан 08:30–20:00 · Бямба 09:00–16:00
Now showing 1 - 9 of 9
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Application of Galectin-3, HBME-1, Cytokeratin-19, and CD56 in the Diagnosis of Thyroid Neoplasm
    (Mongolian National University of Medical Sciences, 2019-06-25) ; ; ;
    Nyamjargal Baatarjalbuu
    ;
    Anarkhuu Bold-Erdene
    Objective: The purpose of this study was to investigate the effectiveness of immunohistochemical thyroid malignancy markers Galectin-3, HBME-1, Cytokeratin-19, and CD56 in the diagnosis of thyroid neoplasm. Methods: The study included a total of 53 cases of thyroid neoplasm on which immunohistochemical IHC staining was performed using the manual staining method. Results: The histopathological diagnosis of thyroid nodules was papillary thyroid carcinoma in 40 (75.5%), follicular thyroid carcinoma in 3 (5.7%), follicular adenoma in 8 (15.1%), medullary thyroid carcinoma in 1 (1.9%), and Hurthle cell carcinoma in 1 (1.9%). Out of 40 cases of papillary thyroid carcinoma, Galectin-3 and CK19 were positive in 36 (90%) cases while expression of HBME1 was seen in 32 (80%) papillary thyroid carcinoma cases, and 16 (40%) stained positive for CD56. For the three follicular thyroid carcinoma cases, CD56 was positive in one case, but the marker was positive in 7 out of 8 cases (87.5%) of follicular adenoma. Conclusion: Our results suggest Galectin-3 and HBME-1 are the most sensitive diagnostic markers for differentiating papillary carcinoma from follicular neoplasm.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Determination of Survival Time Following Isolated Head Trauma by Histopathological Method
    (Mongolian National University of Medical Sciences, 2018-12-29) ;
    Zhi Xiong Wang
    ;
    ; ;
    Objectives: The objectives of this study were determine the demographic characteristics of patients who died from isolated head injuries having no surgery and to determine their survival time based on histopathological changes in the injury hematoma and brain. Methods: Between 2016 and 2017 the Department of Forensic Medicine of the National Institute Forensic Science recorded 3640 deaths of which 757 cases had skull and brain trauma. A subset of 372 of these patients with isolated head trauma who did not have surgery were analyzed. The tissues from 30 of these patients underwent histopathological analysis to determine the time from injury to death. Results: Out of 372 cases studied, 152 (83%) were male, 32 (17%), were female (male to female ratio 5:1) and most (n=53, 28.8%) were within 40-49 years of age (mean age 42±15.9). Trauma to the anterior head was the most common location of injury (257, 69.1%). We identified 30 cases to estimate time from injury to death by histological examination using Martius Scarlet Blue stain. Among these cases 10 died between 0-6 hours after head trauma, 2 died between 6-12 hours, 13 cases died between 12-18 hours, 3 cases died between 18- 24 hours, 1 case died 24-48 hours, and 3 cases died 48 hours after head injury. Conclusion: Males who suffered death from traumatic head injuries from blunt objects were most frequently identified in our research. Brain edema, subarachnoid hemorrhage, frontal skull fracture and brain contusion were most common. The interval of time from the head trauma to death was determined by the age of the fibrin using histochemistry stain.
  • Some of the metrics are blocked by your 
    Item type:Publication,
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Impact of IDH1 Mutation on Long-Term Survival in Patients with Diffuse Glioma
    (Mongolian National University of Medical Sciences, 2019-03-31)
    Enkhee Ochirjav
    ;
    ;
    Gheeyoung Choe
    ;
    Objectives: Diffuse brain gliomas are common primary brain tumor associated with a poor prognosis. In this study, we aimed to determine the impact of IDH1 mutation status on long term survival. Methods: Patients who underwent surgery for diffuse brain glioma were selected. Based on IDH1 mutation status, patients were separated into IDH1 mutant and IDH1 wildtype groups. Results: A total of 124 patients with diffuse brain tumor were included (mean age 39±17, 48.4% male). The frequency of IDH1 mutant and IDH1 wildtype were 56.5% (n=70) and 43.5% (n=54), respectively. During follow-up, 76 patients (61.3%) died and the median follow-up was 8 months (IQR 4; 16). Patients with IDH1 mutant more likely younger (36±16 vs. 43±17, p<.05) and had low grade (grade II) tumor (64.3% vs. 20.4%, p<.001). After adjustment of possible predictors, such age, gender, tumor location and surgical type, IDH1 mutant was an independent predictor of all-cause mortality (HR=0.43, 95% CI 0.26- 0.71, p<.001). Kaplan-Meier estimation showed IDH1 mutant is associated with longer survival compared with IDH1 wildtype in low grade tumor (log rank p<.001). Conclusion: Mutated IDH1 is an independent predictor of all-cause mortality in patients with diffuse brain glioma and resulted in longer survival compared with IDH1 wildtype.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Prognostic Value of Immunohistochemical Biomarkers in Patients with Astrocytic Brain Tumor
    (Mongolian National University of Medical Sciences, 2018-09-25)
    Enkhee Ochirjav
    ;
    Bolortuya Dorj
    ;
    ;
    Objectives: Astrocytoma is a common primary malignant brain tumor and it is typically associated with poor outcome. In this study, we aimed to determine role of various immunohistochemical (IHC) biomarkers and their relationship with patient prognosis. Methods: Patients who underwent surgery for astrocytic brain tumor were selected. Tissue specimens were collected from surgically removed tumors and stained by various IHC stains. All-cause mortality was chosen for study endpoint. Results: A total of 133 patients with who underwent surgery for astrocytic brain tumor were included (mean age 38±19 and 49.6% male). During follow-up, 84 patients (63%) died and the median time of death was 8 months (IQR 4; 16) after hospital discharge. Patients who died had higher tumor grade (60.7% vs. 34.7%, p<0.01). After adjustment of possible predictors, surgical type (HR=0.51, 95% CI 0.31-0.82, p<0.01), expression level of Ki67 (HR=1.02, 95% CI 1.00-1.04, p<0.05) and p53 (HR=1.01, 95% CI 1.00-1.02, p<0.05) were independently associated with long term mortality. Kaplan-Meier estimation showed overexpression of WT1 (42% vs. 52%, p<0.05) and Ki67 (27% vs. 58%, p<0.001) are associated with poor survival. Conclusion: IHC biomarkers are independently associated with long term prognosis in patients with astrocytic brain tumor. Overexpression of WT1 and Ki67 marker are associated with poor survival.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Reclassification of Mongolian Diffuse Gliomas According to the Revised 2016 World Health Organization Central Nervous System Tumor Classification
    (The Korean Society of Pathologists and The Korean Society for Cytopathology, 2019-09)
    Ochirjav, Enkhee
    ;
    ; ;
    Choe, Gheeyoung
    BACKGROUND: The 2016 World Health Organization (WHO) classification of central nervous system (CNS) tumors has been modified to incorporate the IDH mutation and 1p/19q co-deletion in the diagnosis of diffuse gliomas. In this study, we aimed to evaluate the feasibility and prognostic significance of the revised 2016 WHO classification of CNS tumors in Mongolian patients with diffuse gliomas. METHODS: A total of 124 cases of diffuse gliomas were collected, and tissue microarray blocks were made. IDH1 mutation was tested using immunohistochemistry, and 1p/19q co-deletion status was examined using fluorescence in situ hybridization analysis. RESULTS: According to the 2016 WHO classification, 124 cases of diffuse brain glioma were reclassified as follows: 10 oligodendroglioma, IDHmut and 1p/19q co-deleted; three anaplastic oligodendroglioma, IDHmut and 1p/19q co-deleted; 35 diffuse astrocytoma, IDHmut, 11 diffuse astrocytoma, IDHwt, not otherwise specified (NOS); 22 anaplastic astrocytoma, IDHmut, eight anaplastic astrocytoma, IDHwt, NOS; and 35 glioblastoma, IDHwt, NOS, respectively. The 2016 WHO classification presented better prognostic value for overall survival in patients with grade II tumors than traditional histological classification. Among patients with grade II tumors, those with oligodendroglioma IDHmut and 1p/19q co-deleted and diffuse astrocytoma IDHmut showed significantly higher survival than those with diffuse astrocytoma IDHwt, NOS (p<.01). CONCLUSIONS: Mongolian diffuse gliomas could be reclassified according to the new 2016 WHO classification. Reclassification revealed substantial changes in diagnosis of both oligodendroglial and astrocytic entities. We have confirmed that the revised 2016 WHO CNS tumor classification has prognostic significance in Mongolian patients with diffuse gliomas, especially those with grade II tumors.
    Scopus© Citations 2
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Human papillomavirus genotyping among women with cervical abnormalities in Ulaanbaatar, Mongolia
    (Elsevier BV, 2018-12) ;
    Yoshida, Tomomi
    ;
    ;
    Gotov, Uyanga
    ;
    Sharkhuu, Enkhtuya
    OBJECTIVES: Few studies on human papillomavirus (HPV) have been conducted in Mongolia. This study was performed to evaluate the prevalent HPV genotypes and their associations with cytology and demographic and behavioral characteristics in Mongolian women with cervical abnormalities. METHODS: Exfoliated cell samples of 100 women who had a previous history of cervical abnormality were collected. Cytological interpretation was conducted microscopically and HPV genotyping was performed using the Roche Linear Array test. Study questionnaires were completed. RESULTS: Overall, 25 HPV genotypes were detected in 47% of participants, and the most prevalent were HPV 16, 52, 58, and 33. Cytological examination revealed 12% of participants had atypical squamous cells of undetermined significance (ASC-US), 8% had low-grade squamous intraepithelial lesions (LSIL), 7% had high-grade squamous intraepithelial lesions (HSIL), and 14% had squamous cell carcinoma (SCC), while 59% of women had a normal cytology. HPV 16 was the most common type among women with a normal cytology and cervical cancer. However, women with cervical abnormalities including LSIL and HSIL were predominantly infected with HPV 52. Moreover, women aged <35 years had a significantly higher risk of HPV infection than those in the other age groups (p<0.05). CONCLUSIONS: The prevalent trend of HPV genotypes observed in this cohort differs from that reported previously in Mongolia. These data may contribute to developing an effective strategy for cervical cancer prevention in Mongolia.
    Scopus© Citations 11
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Mongolian and Japanese Joint Conference on "Echinococcosis: diagnosis, treatment and prevention in Mongolia" June 4, 2009
    (Springer Science and Business Media LLC, 2010-12)
    Gurbadam, A
    ;
    Nyamkhuu, D
    ;
    Nyamkhuu, G
    ;
    Tsendjav, A
    ;
    Sergelen, O
    Scopus© Citations 16
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Wireless monitoring method for diabetic foot temperature
    (IEEE, 2017)
    Erdenechimeg, D.
    ;
    Enkhzul, D.
    ;
    Munkhtamir, O.
    ;
    Scopus© Citations 7